FDA meeting minutes for BNTC point to a 1-year natural history control group, a Phase 3 single-arm study and a 6-month interim endpoint. Michael Taylor called the update positive, saying enrollment could be rapid with a readout in 2H 2027.
published
FDA meeting minutes for BNTC point to a 1-year natural history control group, a Phase 3 single-arm study and a 6-month interim endpoint. Michael Taylor called the update positive, saying enrollment could be rapid with a readout in 2H 2027.
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.